Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-12

FDA Approved: MESALAMINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for mesalamine from Zydus Lifesciences Limited, adding a generic option for the treatment of ulcerativ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)